共查询到20条相似文献,搜索用时 187 毫秒
1.
2.
3.
亚氨基二乙酸酯(NH(CH2COOR)2,R=Me、Et、t-Bu)与C60的光化学反应制得C60吡咯烷衍生物2, 产率为55%-36%(基于已反应的C60),反应活性与R基的空间效应有关,反应活性的顺序为R=Me>Et> t-Bu。C60吡咯烷衍生物2(R=Me)用Nail、CH,OH水解后,经盐酸酸化得相应的羧酸衍生物3,产率为65% (基于C60吡咯烷衍生物2)。C60吡咯烷衍生物2和3的结构为1H NMR、13C NMR、IR和元素分析所证实。用化学发光法检测了C60羧酸衍生物3对邻苯三酚自氧化产生的超氧阴离子(O2-·)的清除效果。结果表明,C60羧酸衍生物3能有效地清除O2-·,并且有明显的量效关系。当C60羧酸衍生物3浓度为0.3 mmol/L时,清除效率可达70%。讨论了结构因素对C60衍生物清除活性的影响。 相似文献
4.
5.
6.
7.
以L-谷氨酸和苯甲醛为起始原料,经7步反应合成了重要中间体(2S,5R)-1-苄基-5-(2-羟乙基)吡咯烷-2-羧酸叔丁酯(1),总产率19%;1经TBDMSCl保护羟基后,用10%Pd/C催化氢解去除苄基制得游离胺(2S,5R)-5-(2-二甲基叔丁基硅氧烷基乙基)吡咯烷-2-羧酸叔丁酯(3);3与Boc-β-Cl-ala,在碱性条件下偶合得氯代烃消去产物(2S,5R)-1-[(2-叔丁氧甲酰胺基)丙烯酰基]-5-(2-二甲基叔丁基硅氧烷基乙基)吡咯烷-2-羧酸叔丁酯(4),或在中性条件下偶合得(2S,5R)-1-[(R)-2-叔丁氧甲酰胺基-3-氯丙酰基]-5-(2-二甲基叔丁基硅氧烷基乙基)吡咯烷-2-羧酸叔丁酯(5);4或5经四丁基氟化铵去除TBDMS保护并发生关环反应合成了新型的七元醚环化合物(4R,7S,9R)-4-甲基-4-叔丁氧甲酰胺基-5-羰基-3-氧杂氮杂卓[1,4]并吡咯[1,2-d]-7-羧基叔丁酯(简称6);6于室温在氯仿中静置2 d~3 d自发转换为其构象异构体(4S,7S,9R)-6(简称6’,6/6’=1/9),其结构经1H NMR,13C NMR,2D NMR和HR-ESI-MS表征。 相似文献
8.
C60吡咯烷羧酸衍生物的合成及其清除超氧阴离子自由基(O )的活性 总被引:3,自引:0,他引:3
亚氨基二乙酸酯(NH(CH2COOR)
2 ,R=Me、Et、t-Bu)与C60的光化学反应制得C60吡咯烷衍生物2,产率为 55%~36%
(基于已反应的C60),反应活性与R基的空间效应有关,反应活性的顺序为R=Me>Et>t-Bu.
C60吡咯烷衍生物2(R=Me)用NaH、CH3OH水解后,经盐酸酸化得相应的羧酸衍生物3,产率为65%(基于C60吡咯烷衍生物2).
C60吡咯烷衍生物2和3的结构为1H NMR、13C NMR、IR和元素分析所证实.
用化学发光法检测了C60羧酸衍生物3对邻苯三酚自氧化产生的超氧阴离子(O2-·)的清除效果.
结果表明,C60羧酸衍生物3能有效地清除O2-· ,并且有明显的量效关系.
当C60羧酸衍生物3浓度为0.3 mmol/L时,清除效率可达70%.
讨论了结构因素对C60衍生物清除活性的影响. 相似文献
9.
10.
11.
以4-哌啶酮为原料,经过胺基保护、缩合、环合、脱保护等步骤,设计合成了一系列新型的5,6,7,8-四氢咪唑并[2',1':2-3]噻吩并[5,4-c]哌啶类化合物。通过核磁共振波谱仪(~1H NMR、~(13)C NMR)、质谱(MS)和元素分析确证了其结构。对其体外活性研究发现,该类化合物对乳腺癌细胞MCF-7具有一定的抑制活性,其中化合物5a的抑制活性最为显著,半数抑制浓度(IC_(50))值达到了8.6μmol/L。为此类化合物的抗肿瘤活性研究提供了参考。 相似文献
12.
为寻找更为有效的抗肿瘤药物,改善汉防己甲素的抗肿瘤活性,本文以汉防己甲素为原料,经过Suzuki反应设计并合成了6个新的双苄基异喹啉类衍生物。新化合物经过质谱(MS)、核磁共振氢谱(~1H NMR)、核磁共振碳谱(~(13)C NMR)等技术手段进行了结构确证。采用细胞计数试剂盒(CCK-8)法初步评价了6个新化合物对人肺癌细胞(A549)和小鼠白血病细胞(P388)的抗肿瘤活性。结果表明,化合物均有不同程度的抗肿瘤活性,其中化合物H1、H4、H6对A549细胞的抗肿瘤活性(IC5010μmol/L)明显优于阳性对照汉防己甲素。 相似文献
13.
为了寻找高效低毒的抗肿瘤候选化合物, 以去氢骆驼蓬碱为原料, 对β-咔啉环的2-,7-和9-位3个结构位点进行了结构改造, 合成了11个去氢骆驼蓬碱衍生物, 化合物的结构经核磁共振、 红外光谱、 质谱及元素分析确证. 采用四甲基偶氮唑盐(MTT)法初步测试了目标化合物体外抗肿瘤(Bel-7402, 786-0, BGC-823, A375, 769-P和MCF7)活性, 结果表明化合物4a, 4b, 8a和8b具有显著的体外抗肿瘤活性. 相似文献
14.
根据活性亚结构拼接原理,通过紫罗兰酮与(取代)苯甲醛反应合成了紫罗兰酮基双查尔酮,然后经与氨基硫脲缩合得到一系列未见报道的新型含紫罗兰酮、查尔酮及氨基硫脲3种优势结构单元的杂化体,它们的化学结构经傅里叶变换红外光谱(FT-IR)、核磁共振波谱(~1H NMR、~(13)C NMR)、元素分析及质谱(MS)等测试技术所证实。采用溴化噻唑蓝四氮唑(MTT)法初步测定其体外抗肿瘤活性(乳腺癌细胞(MCF-7),肝癌细胞(Hep G2),肺癌细胞(A549)),结果表明,对于不同类型的肿瘤细胞,化合物展现较好的增殖抑制活性。尤其是化合物3a与3b对MCF-7细胞展现较强的抗增殖活性,半数致死量(IC_(50))值分别为10.83和7.62μmol/L,化合物3e对A549细胞显示一定的增殖抑制活性效果(IC_(50)值为13.36μmol/L),化合物3f对Hep G2细胞表现了高效的抗增殖活性(IC_(50)值为8.55μmol/L)。目标物的抗增殖活性与紫罗兰酮结构及查尔酮环上不同电子效应的取代基有关。 相似文献
15.
合成了一系列新型O-糖基-甲氧甲酰基膦酰胺酯,并对O-糖基亚磷酰胺酯与氯甲酸甲酯的Arbuzov反应及其它有关反应进行了讨论。产物的结构经1HNMR、31PNMR、IR及元素分析确定。初步的生物活性测定结果表明,化合物3e对人肝癌Bel-7402细胞和人白血病HL-60细胞有一定的抑制作用。化合物3a对烟草花叶病毒有一定的抑制活性。 相似文献
16.
A series of novel chalcone derivatives was designed and synthesized via a suitable synthetic strategy in good yields using commercially available 2-amino-4-nitrophenol as an initiator. The structures of the target compounds were confirmed by means of 1H NMR, 13C NMR and high-resolution mass spectrometry(HRMS). And the ability of the target compounds to inhibit influenza viruses was evaluated. These compounds showed moderate inhibitory activity against influenza A(H9N2 and H5N1) viruses. Within this series, compounds S14 and S15 with good potency(IC50=40.3-51.5μmol/L) could be used as lead compounds in the future. 相似文献
17.
A novel series of 5H-pyridazino[4,5-b]indoles(L-01-L-32) was synthesized and characterized by means of 1H NMR, MS and elemental analysis. The cytotoxicity of the target compounds against Bel-7402 and HT-1080 cell lines were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT) assay. Most of them exhibited moderate to excellent cytotoxicity, and six compounds(L-04, L-06, L-18, L-20, L-21 and L-23) possessed dramatically increased cytotoxicity superior to Gefitinib. Of these initial hits, compound L-21 displayed remarkable cytotoxicity against the tested cell lines with half maximal inhibitory concentration(IC50) values of 4.6 and 2.1 μmol/L, respectively, which was 13.9- to 25.6-fold more potent than positive control. 相似文献
18.
Two novel series of sixteen aminoalkyl-substituted polymethoxychalcone derivatives 2a-2h and 3a-3h were synthesized from 2'-hydroxy-3,4,5,4',6'-pentamethoxy chalcone(1) through extending alkoxy side chain at the 2'-position, and introducing amine hydrogen bond receptor at the end of the side chain. The structures of all the synthesized compounds were confirmed by 1H NMR, 13C NMR and MS techniques. Furthermore, all the compounds were tested for antiproliferative activities in vitro against a panel of three human cell lines(HeLa, HCC1954 and SK-OV-3) via CCK-8 assay. The results show that all the target compounds exhibit antiproliferative activities against the three human cancer cells with IC50 values of 4.62-48.21 μmol/L, except compound 2h against SK-OV-3 cells. Most of these compounds were more active when compared to the positive control cis-Platin. 相似文献
19.
Pingxuan Jiao Shouxin Wang Shuobin Liang Man Li Qianqian Gao Dezhong Ji Yingying Chen Haiwei Li Fuxiang Ran Yongmin Zhang Lihe Zhang Demin Zhou Sulong Xiao 《中国化学快报》2019,30(3):690-693
Four water-soluble β-CD-pentacyclic triterpene conjugates were synthesized via ester and amide linkages. All the conjugates showed lower hydrophobicity (AlogP) than their parent. 相似文献
20.
An ultrasonic-assisted synthesis of bis-isoxazole derivatives was developed. Eight 3-(6-chloropyridin-3-yl)-5-{[(3-aryli-soxazol-5-yl)methoxy]methyl}isoxazoles were synthesized by 1,3-dipolar cycloaddition reaction between substituted isoxazolyl alkyne compounds and 6-chloro-N-hydroxynicotinimidoyl chloride. The structures of the synthesized compounds were confirmed by HRMS, FTIR, 1H and 13C NMR spectroscopy. Wherein, the antifungal and antibacterial activities of target compounds were tested. The synthesized compounds 6a and 6h exhibited better antifungal activity in comparison with the standard drug itraconazole. The minimum inhibitory concentrations(MICs) of both compound 6a and compound 6h were both 4 μg/mL against Candida albicans ATCC 10231. 相似文献